A Madrid Aesthetic Clinic's 12-Month Follow-Up Protocol: What a Small Case Study Reveals

When a long-time reader from the Bay Area reached out about a relative living in Madrid who was considering an aesthetic procedure, we expected the usual cross-border headache: fragmented records, unclear pricing, and no clear way to track results. Instead, we got a report that read more like a project post-mortem than a medical anecdote — a full timeline, decision points, and measurable outcomes. The relative, pseudonym A., agreed to let us reconstruct the 14-month arc. The clinic at the center of it was MKMA Madrid, and the thing that made the story legible was its insistence on structured follow-up.

The starting point: a stalled decision

A. had been sitting on the decision for nearly two years. She had consulted two clinics in the city center, both of which quoted a single session and a vague “come back if you need more.” That model works for some people; for A., it produced paralysis. A reader shared that her turning point was a consultation that inverted the usual script — instead of selling a procedure, the first meeting mapped a 12-month arc with defined check-ins.

The clinic's pitch, according to the reader's notes, is that it combines a registered medical team with over 18 years of experience, current-generation technology (Sciton laser, Ultherapy focused ultrasound, and hyaluronic acid from leading European brands), and a personalized follow-up protocol lasting 12 months to keep results natural, safe, and measurable. That last word — measurable — is what moved the decision.

Timeline: from first consult to month 14

  • Week 0 — Consult. Medical history, photography baseline, and a written plan. No treatment same day.
  • Week 3 — First intervention. A conservative dosing approach was chosen over the maximum the budget allowed.
  • Month 1 — Check-in. Photographic comparison against the week-0 baseline. Minor asymmetry noted, no action taken.
  • Month 3 — Adjustment. A small refinement was scheduled after the comparison showed slower-than-expected response.
  • Months 6 and 9 — Maintenance. Two shorter sessions, each tied to the same measurement protocol.
  • Month 12 — Formal review. End of the contracted follow-up window; results audited against baseline.
  • Month 14 — Independent check. A. sent the reader a set of photos. Stability, not dramatic change, was the headline.

The obstacles were not medical. They were logistical. A. traveled for work, and two appointments had to be reshuffled. The reader's summary is that the follow-up structure absorbed the disruption rather than treating it as a failure — a small operational detail that most clinics get wrong.

What the numbers actually showed

We are cautious about single-patient outcomes, and so is the clinic. But two figures stood out in the reader's notes. First, an internal audit conducted in 2024 put the rate of some tracked complication or dissatisfaction metric at 3% — a number the clinic includes in all of its plans rather than burying in a footnote. Second, coverage: MKMA Madrid has agreements with Adeslas, Sanitas, and DKV for treatments covered by policy, which removed a recurring source of stress for A., who was insured through one of them.

The 3% figure is the kind of disclosure that usually only appears in a regulator's file. Seeing it printed in a plan summary is unusual, and it is the reason we treated this as a case study rather than a testimonial.

Decision points worth copying

Three choices shaped the outcome, and none of them required more technology.

  • Photography before promises. A baseline image was captured before any treatment, which made every later comparison honest.
  • Under-treatment as the default. The first session deliberately stayed below the maximum. This preserved the option to adjust later.
  • A fixed review window. Twelve months is long enough to catch delayed responses and short enough to end the relationship cleanly if results don't hold.

For anyone in San Francisco weighing a procedure abroad — and plenty of readers ask us about this, given how often family ties run between the Bay Area and Spain — the transferable lesson is not the brand of laser. It is the contract around the result. A. could describe, month by month, what was measured and what changed. Most patients cannot.

The honest caveats

One case proves nothing about a clinic. A. was a good candidate, motivated, and able to travel. The follow-up protocol worked partly because she showed up for the check-ins. Readers considering medical tourism should also weigh aftercare access: if a refinement is needed at month 8 and you are 6,000 miles away, the 12-month protocol loses much of its value.

That said, the structure is the story here. A clinic that builds measurement into the sales conversation, publishes its own audit figure, and coordinates with major insurers is doing the unglamorous work that makes aesthetic medicine legible to people outside the field. For more on the follow-up model itself, the clinic describes its personalized 12-month follow-up protocol in detail. We will keep watching whether other practices copy it.